Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion type Assertion NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_head.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion wasGeneratedBy ECO_0000203 NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_provenance.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion wasDerivedFrom befree-2016 NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_provenance.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion SIO_000772 24807674 NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_provenance.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion evidence source_evidence_literature NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_provenance.
- NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_assertion description "[Taken together, our results suggest that Gal-3 modulates uPAR expression via the MEK/ERK pathway, and that Gal-3 may be a potential therapeutic target for the treatment of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180473.RAhwsTNy9h6Wgzf7kAiJvecpamqI9-Rm9Q_grlSz1SyMU130_provenance.